Sign Up to like & get
recommendations!
0
Published in 2021 at "ACS infectious diseases"
DOI: 10.1021/acsinfecdis.0c00803
Abstract: Bumped kinase inhibitors (BKIs) that target Cryptosporidium parvum calcium-dependent protein kinase 1 have been well established as potential drug candidates against cryptosporidiosis. Recently, BKI-1649, with a 7H-pyrrolo[2,3-d]pyrimidin-4-amine, or "pyrrolopyrimidine", central scaffold, has shown improved efficacy…
read more here.
Keywords:
kinase inhibitors;
bumped kinase;
pyrrolopyrimidine bumped;
inhibitors treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00147-18
Abstract: ABSTRACT Recent reports highlighting the global significance of cryptosporidiosis among children have renewed efforts to develop control measures. We evaluated the efficacy of bumped kinase inhibitor (BKI) 1369 in the gnotobiotic piglet model of acute…
read more here.
Keywords:
bumped kinase;
hominis;
efficacy bumped;
bki 1369 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01425-22
Abstract: Recent advances on the development of bumped kinase inhibitors for treatment of cryptosporidiosis have focused on the 5-aminopyrazole-4-carboxamide scaffold, due to analogs that have less hERG inhibition, superior efficacy, and strong in vitro safety profiles.…
read more here.
Keywords:
efficacy;
treatment cryptosporidiosis;
bumped kinase;
treatment ... See more keywords